<DOC>
	<DOC>NCT00347932</DOC>
	<brief_summary>Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.</brief_summary>
	<brief_title>A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Bacterial</mesh_term>
	<criteria>Must have a diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge and redness in at least one eye. Females of childbearing potential must utilized reliable contraceptive methods and have a negative pregnancy test. Pregnant or nursing females. Known hypersensitivity to fluoroquinolones or to any of the study ingredients. Use of any antibiotic within 72 hours of treatment. Any disease or condition that could interfere with the safety and efficacy evaluations of the study medications. Participation in an ophthalmic drug or device research study within 30 days prior to entry into the study.</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>